Better efficacy of a 12-month interferon alfa-2b retreatment in patients with chronic hepatitis C relapsing after a 6-month treatment: A multicenter, controlled, randomized trial-Reference-Cited by-同舟云学术

Better efficacy of a 12-month interferon alfa-2b retreatment in patients with chronic hepatitis C relapsing after a 6-month treatment: A multicenter, controlled, randomized trial

Published:1998-12 Issue:6 Volume:28 Page:1680-1686
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Payen Jean-Louis,Izopet Jacques,Galindo-Migeot Virginie,Lauwers-Cances Val�rie,Zarski Jean-Pierre,Seigneurin Jean-Marie,Dussaix Elizabeth,Voigt Jean-Jacques,Selves Janick,Barange Karl,Puel Jacqueline,Pascal Jean-Pierre,

Publisher

Wiley

Subject

Hepatology

Reference29 articles.

1. Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis

2. Treatment of Chronic Hepatitis C with Recombinant Interferon Alfa

3. Recombinant Interferon Alfa Therapy for Chronic Hepatitis C

4. A Comparison of Three Interferon Alfa-2b Regimens for the Long-Term Treatment of Chronic Non-A, Non-B Hepatitis

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Evolution of Clinical Trials for Hepatitis C;Topics in Medicinal Chemistry;2019

2. Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C;Cochrane Database of Systematic Reviews;2013-01-31

3. Virological responses of pegylated interferon alpha-2a treatment in hemodialysis patients infected with hepatitis C;Clinical and Experimental Nephrology;2012-07-20

4. Elevation of serum gamma-glutamyltranspeptidase activity is frequent in chronic hepatitis C, and is associated with insulin resistance;Digestive and Liver Disease;2009-08

5. Is physical activity possible and beneficial for patients with hepatitis C receiving pegylated interferon and ribavarin therapy?;Gastroentérologie Clinique et Biologique;2009-01